HRT Financial’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-64,980
| Closed | -$649K | – | 3343 |
|
|
2022
Q4 | $649K | Hold |
64,980
| – | – | 0.01% | 1154 |
|
|
2022
Q3 | $644K | Hold |
64,980
| – | – | 0.01% | 1217 |
|
|
2022
Q2 | $638K | Hold |
64,980
| – | – | 0.01% | 1282 |
|
|
2022
Q1 | $641K | Hold |
64,980
| – | – | ﹤0.01% | 1303 |
|
|
2021
Q4 | $651K | Hold |
64,980
| – | – | ﹤0.01% | 1375 |
|
|
2021
Q3 | $649K | Hold |
64,980
| – | – | ﹤0.01% | 1584 |
|
|
2021
Q2 | $653K | Hold |
64,980
| – | – | 0.01% | 1470 |
|
|
2021
Q1 | $640K | Buy |
+64,980
| New | +$640K | 0.01% | 1423 |
|